FAL
SNY icon

Focused Alpha LLC’s Sanofi SNY Stock Holding History

Focused Alpha LLC’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Buy
6,272
+783
+14% +$35K 0.07% 235
2026
Q1 		$264K Buy
5,489
+1,198
+28% +$55.9K 0.08% 227
2025
Q4 		$208K Buy
+4,291
New +$213K 0.06% 235

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Focused Alpha LLC's SNY Position: Q2 2026 in Review

Focused Alpha LLC increased its Sanofi (SNY) stake by 14% in Q2 2026, buying an estimated $35K and bringing the position to 6,272 shares worth $268K. The position accounts for 0.07% of the portfolio, ranked #235.

Focused Alpha LLC first reported a position in SNY in Q4 2025 and has held it in 3 quarters since. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Focused Alpha LLC held 6,272 shares of Sanofi worth $268K as of Q2 2026.
  • Focused Alpha LLC bought 783 Sanofi shares in Q2 2026, an estimated $35K.
  • Sanofi made up 0.07% of Focused Alpha LLC's portfolio in Q2 2026, its #235 holding.
  • Focused Alpha LLC first reported a position in Sanofi in Q4 2025 and has held it in 3 quarters since.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Focused Alpha LLC's 13F filing for Q2 2026, filed 7 Aug 2026.